Literature DB >> 18239861

The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations.

Jagdeep Shur1, Haggis Harris, Matthew D Jones, J Sebastian Kaerger, Robert Price.   

Abstract

PURPOSE: To investigate the role of in situ generated fine excipient particles on the fluidization and aerosolization properties of dry powder inhaler (DPI) formulations.
MATERIALS AND METHODS: Carrier based DPI formulations were prepared under low and high shear blending. Powder rheometery was utilized to measure bulk powder properties in a consolidated and aerated state. Powder fluidization and aerosolization characteristics were related to bulk powder properties using high speed imaging and inertial impaction measurements.
RESULTS: High shear blending of formulations resulted in the in situ generation of excipient fines, which corresponded to an increase in aerosolization efficiency. The generation of fines were shown to increase the tensile strength and free volume of the carrier, which resulted in a characteristic change in the fluidization properties, as observed by high speed imaging. The increase in minimum fluidization velocity and aerodynamic drag forces required to aerate the powder may provide the source of energy for the increase in fine particle re-suspension.
CONCLUSIONS: The in situ generation of excipient fines affect bulk powder properties of DPI formulations, which directly affects fluidization and aerosolization behaviour of DPI formulations. The study suggests an alternative mode of action by which fines increase DPI formulation performance.

Mesh:

Substances:

Year:  2008        PMID: 18239861     DOI: 10.1007/s11095-008-9538-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect.

Authors:  N M Concessio; M M VanOort; M R Knowles; A J Hickey
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

2.  Fine cohesive powders in rotating drums: Transition from rigid-plastic flow to gas-fluidized regime.

Authors:  A Castellanos; J M Valverde; M A S Quintanilla
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2002-06-12

3.  Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures.

Authors:  A H de Boer; P Hagedoorn; D Gjaltema; J Goede; H W Frijlink
Journal:  Int J Pharm       Date:  2003-07-24       Impact factor: 5.875

Review 4.  Dry powder inhalers for pulmonary drug delivery.

Authors:  H W Frijlink; A H De Boer
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

5.  An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces.

Authors:  Matthew D Jones; Jennifer C Hooton; Michelle L Dawson; Alan R Ferrie; Robert Price
Journal:  Pharm Res       Date:  2007-10-19       Impact factor: 4.200

6.  Types of gas fluidization of cohesive granular materials.

Authors:  Jose Manuel Valverde; Antonio Castellanos
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2007-03-26

7.  General factors influencing drug delivery to the lung.

Authors:  D Ganderton
Journal:  Respir Med       Date:  1997-11       Impact factor: 3.415

8.  Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.

Authors:  X M Zeng; G P Martin; S K Tee; A A Ghoush; C Marriott
Journal:  Int J Pharm       Date:  1999-05-25       Impact factor: 5.875

9.  The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate.

Authors:  S K Tee; C Marriott; X M Zeng; G P Martin
Journal:  Int J Pharm       Date:  2000-11-04       Impact factor: 5.875

10.  The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.

Authors:  Paul M Young; Hak-Kim Chan; Herbert Chiou; Stephen Edge; Terence H S Tee; Daniela Traini
Journal:  J Pharm Sci       Date:  2007-05       Impact factor: 3.534

View more
  22 in total

1.  The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.

Authors:  Roberto Depasquale; Sau L Lee; Bhawana Saluja; Jagdeep Shur; Robert Price
Journal:  AAPS PharmSciTech       Date:  2014-11-15       Impact factor: 3.246

2.  Effects of device and formulation on in vitro performance of dry powder inhalers.

Authors:  Wallace P Adams; Sau L Lee; Robert Plourde; Robert A Lionberger; Craig M Bertha; William H Doub; Jean-Marc Bovet; Anthony J Hickey
Journal:  AAPS J       Date:  2012-04-05       Impact factor: 4.009

3.  Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.

Authors:  Jagdeep Shur; Bhawana Saluja; Sau Lee; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2015-05-09       Impact factor: 4.009

4.  An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.

Authors:  Hanne Kinnunen; Gerald Hebbink; Harry Peters; Jagdeep Shur; Robert Price
Journal:  AAPS PharmSciTech       Date:  2014-04-23       Impact factor: 3.246

Review 5.  In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors:  Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

Review 6.  Administration of dry powders during respiratory supports.

Authors:  Wei-Ren Ke; Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Patricia Tang; Lan Chen; Donghao Chen; Hak-Kim Chan
Journal:  Ann Transl Med       Date:  2021-04

7.  Engineered mannitol ternary additives improve dispersion of lactose-salbutamol sulphate dry powder inhalations.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  AAPS J       Date:  2013-04-17       Impact factor: 4.009

8.  The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.

Authors:  Waseem Kaialy; Hassan Larhrib; Gary P Martin; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

9.  Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

10.  Improving Dry Powder Inhaler Performance by Surface Roughening of Lactose Carrier Particles.

Authors:  Bernice Mei Jin Tan; Lai Wah Chan; Paul Wan Sia Heng
Journal:  Pharm Res       Date:  2016-04-18       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.